COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,252 Articles (22,733 medRxiv, 8,519 bioRxiv)

Most recent first Previous |  Page 1404: Articles 14031-14040  | Next

The risk of severe COVID-19 and mortality from COVID-19 in people living with HIV compared to individuals without HIV - a systematic review and meta-analysis of 1 268 676 individuals.
Mapahla, L., Abdelmaksut, A., Arif, R., Islam, N., Chinhenzva, A., Doi, S. A. R., Chivese, T.
10.1101/2021.07.03.21259958 — Posted: 2021-07-05
Evaluation of the United States COVID-19 Vaccine Allocation Strategy
Islam, M. R., Oraby, T., McCombs, A., Chowdhury, M. M., Al-Mamun, M., Tyshenko, M. G., Kadelka, C.
10.1101/2021.07.01.21259870 — Posted: 2021-07-05
Monitoring SARS-CoV-2 in sewage: toward sentinels with analytical accuracy
Calderon-Franco, D., Orschler, L., Lackner, S., Agrawal, S., Weissbrodt, D. G.
10.1101/2021.06.30.21259751 — Posted: 2021-07-05
SARS-CoV-2 and the role of vertical transmission from infected pregnant women to their fetuses: systematic review.
Pluddemann, A., Spencer, E. A., Heneghan, C., Brassey, J., Onakpoya, I. J., Rosca, E. C., Evans, D. H., Conly, J. M., Jefferson, T.
10.1101/2021.06.30.21259750 — Posted: 2021-07-05
Men and loneliness in the Covid-19 pandemic: insights from an interview study with UK-based men
Ratcliffe, J., Galdas, P., Kanaan, M.
10.1101/2021.06.30.21259536 — Posted: 2021-07-05
Importance of epidemic severity and vaccine mode of action and availability for delaying the second vaccine dose
Berec, L., Levinsky, R., Weiner, J., Smid, M., Neruda, R., Vidnerova, P., Suchoparova, G.
10.1101/2021.06.30.21259752 — Posted: 2021-07-05
Implications of COVID-19 vaccination and public health countermeasures on SARS-CoV-2 variants of concern in Canada: evidence from a spatial hierarchical cluster analysis
Adeyinka, D. A., Camillo, C., Marks, W., Muhajarine, N.
10.1101/2021.06.28.21259629 — Posted: 2021-07-05
COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling
Muhajarine, N., Adeyinka, D. A., McCutcheon, J., Green, K. L., Fahlman, M., Kallio, N.
10.1101/2021.06.28.21259675 — Posted: 2021-07-05
Network-based identification and pharmacological targeting of host cell master regulators induced by SARS-CoV-2 infection
Laise, P., Stanifer, M. L., Bosker, G., Sun, X., Triana, S., Doldan, P., La Manna, F., De Menna, M., Realubit, R. B., Pampou, S., Karan, C., Alexandrov, T., Kruithof-de Julio, M., Califano, A., Boulant, S., Alvarez, M. J.
10.1101/2021.07.03.451001 — Posted: 2021-07-04
Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 Spike Glycoprotein
Stamatakis, G., Samiotaki, M., Temponeras, I., Panayotou, G., Stratikos, E.
10.1101/2021.07.03.450989 — Posted: 2021-07-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).